Prosthetic Heart Valve Devices And Equipment Market Set To Expand From $10.48 Billion In 2026: Growth Outlook Through 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Prosthetic Heart Valve Devices And Equipment Market Size Forecast: How Big Could The Market Get By 2030?
The market for prosthetic heart valve devices and equipment has shown significant growth in recent years. Its value is anticipated to rise from $6.73 billion in 2025 to $7.17 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. This past expansion can be linked to factors like the escalating incidence of valvular heart conditions, an expanding senior demographic, the proliferation of cardiac surgery programs, increasing acceptance of valve replacement procedures, and enhancements in cardiac imaging technologies.
The prosthetic heart valve devices and equipment market size is projected to undergo substantial growth in the upcoming years, with expectations to reach $10.48 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.9%. This forecasted expansion is primarily driven by an increasing preference for minimally invasive cardiac interventions, a rising demand for longer-lasting valve implants, the broadening of transcatheter valve indications, growing investments in the treatment of structural heart disease, and enhanced innovation in biological valve materials. Significant trends anticipated during this period include the increasing adoption of transcatheter heart valve procedures, a surging demand for tissue-based heart valves, the growing utilization of minimally invasive valve repair systems, the expansion of advanced valve durability technologies, and an amplified focus on patient-specific valve solutions.
Get A Free Sample Report With In-Depth Market Insights:
Prosthetic Heart Valve Devices And Equipment Market Growth Backed By Core Demand Fundamentals
The increasing occurrence of valvular heart disease has fueled the demand for transcatheter aortic valve replacement (TAVR) procedures, consequently propelling the prosthetic heart valve devices and equipment market. TAVR is a minimally-invasive surgical intervention performed to treat aortic stenosis, a type of valvular heart disease impacting the heart’s aortic valve. Aortic stenosis hardens the aortic valve, impeding proper blood flow, and TAVR serves to replace this compromised valve with a transcatheter one. As an illustration, in May 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that over 695,000 individuals in the US succumbed to heart disease, representing one out of every five deaths. With the escalating rate of valvular heart diseases, a rise in TAVR procedures is anticipated, subsequently boosting the demand for transcatheter valves and thereby furthering the market’s growth.
Prosthetic Heart Valve Devices And Equipment Market Segment Analysis And Revenue Potential
The prosthetic heart valve devices and equipment market covered in this report is segmented –
1) By Product Type: Repair Products, Mitral Valve Repair Devices, Tricuspid Valve Repair Devices
2) By Valve Type: Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve
3) By Technology: Biological Valve, Decellularized Valve
4) By Application: Hospitals, Ambulatory Surgery Centres
Subsegments:
1) By Repair Products: Transcatheter Mitral Valve Repair (TMVR) Devices, Transcatheter Tricuspid Valve Repair (TTVR) Devices
2) By Mitral Valve Repair Devices: Mitral Valve Repair Systems (MitraClip), Mitral Valve Annuloplasty Devices, Edge-to-Edge Repair Devices
3) By Tricuspid Valve Repair Devices: Tricuspid Valve Annuloplasty Devices, Tricuspid Valve Repair Systems
Prosthetic Heart Valve Devices And Equipment Market Growth Trends Reshaping The Competitive Landscape
Key companies operating in the prosthetic heart valve devices and equipment market are actively developing tricuspid valve replacement systems. This development aims to address the growing demand for effective treatments for tricuspid valve disease, improve patient outcomes, and reduce complications associated with traditional heart valve surgeries. These tricuspid valve replacement systems are medical devices specifically designed to replace the tricuspid valve in the heart, which is responsible for controlling blood flow between the right atrium and right ventricle. For example, in October 2023, Edwards Lifesciences, a US-based technology company, obtained CE Mark approval for its EVOQUE system, making it the world’s first transcatheter valve replacement therapy to be approved for the treatment of tricuspid regurgitation (TR). The EVOQUE valve incorporates a nitinol self-expanding frame and features tissue leaflets crafted from bovine pericardial tissue. It is engineered for delivery through a low-profile transfemoral 28-French system and will be made available in three sizes.
Prosthetic Heart Valve Devices And Equipment Market Competitive Overview And Top Companies
Major companies operating in the prosthetic heart valve devices and equipment market are Boston Scientific Corporation, Edwards Lifesciences, Medtronic plc, LivaNova plc, Abbott Laboratories, Jenavalve Technology Inc., Lepu Medical Technology, Cryolife Inc., Neovasc Inc., Braile Biomedica, Colibri Heart Valve, TTK Healthcare Ltd., Medical Technology Est., Micro Interventional Devices Inc., Well Health Technologies, On-X Life Technologies Inc., Meril Life Sciences Pvt. Ltd., Sorin Group, Commonwealth Edison Company, Cardiac Dimensions Inc., CardioSolutions Inc., Leman Cardiovascular, MitralSolutions Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Xeltis AG, Transcatheter Technologies GmbH, Venus Medtech (Hangzhou) Inc., MValve Technologies Ltd., MVRx Inc., NaviGate Cardiac Structures Inc., Pulmonx Corporation, Tendyne Holdings Inc., ValveXchange Inc., Vascutek Ltd., XpandOrtho Inc., Zhejiang A&F Medical Co. Ltd.
View The Full Prosthetic Heart Valve Devices And Equipment Market Report:
Prosthetic Heart Valve Devices And Equipment Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in global prosthetic heart valve devices and equipment market in 2025. Western Europe was the second-largest region in prosthetic heart valve devices and equipment market. The regions covered in the prosthetic heart valve devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
